PulteGroup Inc. (PHM - Free Report) is slated to report third-quarter 2019 results on Oct 22, before the opening bell.
In the last reported quarter, the company’s earnings and revenues surpassed the Zacks Consensus Estimate by 4.9% and 0.5%, respectively. Notably, it surpassed earnings estimates in each of the trailing 11 quarters.
This homebuilder’s second-quarter earnings and revenues decreased 3.4% each from the year-ago reported figure.
How are Estimates Faring?
Let’s take a look at the estimate revision trend in order to get a clear picture of what analysts are thinking about the company prior to the earnings release.
The Zacks Consensus Estimate for the quarter to be reported is currently pegged at 92 cents per share, remaining unchanged over the past 30 days. This indicates a decrease of 8.9% from the year-ago reported figure of $1.01 per share. Revenues are expected to be $2.6 billion, suggesting 1.7% year-over-year decline.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
PulteGroup Inc. (PHM - Free Report) is slated to report third-quarter 2019 results on Oct 22, before the opening bell.
In the last reported quarter, the company’s earnings and revenues surpassed the Zacks Consensus Estimate by 4.9% and 0.5%, respectively. Notably, it surpassed earnings estimates in each of the trailing 11 quarters.
This homebuilder’s second-quarter earnings and revenues decreased 3.4% each from the year-ago reported figure.
How are Estimates Faring?
Let’s take a look at the estimate revision trend in order to get a clear picture of what analysts are thinking about the company prior to the earnings release.
The Zacks Consensus Estimate for the quarter to be reported is currently pegged at 92 cents per share, remaining unchanged over the past 30 days. This indicates a decrease of 8.9% from the year-ago reported figure of $1.01 per share. Revenues are expected to be $2.6 billion, suggesting 1.7% year-over-year decline.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PHM - FREE
Get the latest research report on MTH - FREE
Get the latest research report on MLM - FREE